WCM Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,972
Closed -$4.58M 257
2025
Q1
$4.58M Sell
27,972
-656
-2% -$103K 0.01% 176
2024
Q4
$4.1M Buy
28,628
+16,462
+135% +$2.55M 0.01% 192
2024
Q3
$1.96M Buy
12,166
+9,409
+341% +$1.5M ﹤0.01% 205
2024
Q2
$402K Buy
2,757
+1,066
+63% +$159K ﹤0.01% 238
2024
Q1
$267K Buy
1,691
+107
+7% +$17K ﹤0.01% 230
2023
Q4
$248K Buy
+1,584
New +$243K ﹤0.01% 229
2015
Q4
Sell
-3,061
Closed -$286K 102
2015
Q3
$286K Sell
3,061
-966
-24% -$93.4K 0.01% 98
2015
Q2
$392K Sell
4,027
-25
-0.6% -$2.5K 0.01% 102
2015
Q1
$408K Sell
4,052
-325
-7% -$33K 0.01% 126
2014
Q4
$458K Sell
4,377
-90
-2% -$9.48K 0.01% 101
2014
Q3
$476K Hold
4,467
0.01% 98
2014
Q2
$467K Buy
4,467
+75
+2% +$7.58K 0.01% 123
2014
Q1
$431K Buy
4,392
+85
+2% +$7.88K 0.02% 119
2013
Q4
$394K Hold
4,307
0.01% 117
2013
Q3
$373K Sell
4,307
-2,187
-34% -$196K 0.02% 110
2013
Q2
$558K Buy
+6,494
New +$551K 0.03% 112

Other funds holding JNJ

WCM Investment Management's JNJ Position: Q2 2025 in Review

WCM Investment Management sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 27,972 shares — an estimated $4.58M sold.

WCM Investment Management first reported a position in JNJ in Q2 2013 and held it in 16 quarters. The position peaked at $4.58M in Q1 2025. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • WCM Investment Management reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • WCM Investment Management sold 27,972 Johnson & Johnson shares in Q2 2025, an estimated $4.58M.
  • WCM Investment Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 16 quarters.
  • WCM Investment Management's Johnson & Johnson position peaked at $4.58M in Q1 2025.
  • 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on WCM Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.